N

Nightingale Health Oyj
OMXH:HEALTH

Watchlist Manager
Nightingale Health Oyj
OMXH:HEALTH
Watchlist
Price: 3.14 EUR 15.02%
Market Cap: 189.5m EUR
Have any thoughts about
Nightingale Health Oyj?
Write Note

Nightingale Health Oyj
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Nightingale Health Oyj
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
N
Nightingale Health Oyj
OMXH:HEALTH
Cash from Financing Activities
-€2.8m
CAGR 3-Years
N/A
CAGR 5-Years
-48%
CAGR 10-Years
N/A
T
Terveystalo Oyj
OMXH:TTALO
Cash from Financing Activities
-€126.6m
CAGR 3-Years
-1%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
P
Pihlajalinna Oyj
OMXH:PIHLIS
Cash from Financing Activities
-€87.9m
CAGR 3-Years
-59%
CAGR 5-Years
-39%
CAGR 10-Years
N/A
No Stocks Found

Nightingale Health Oyj
Glance View

Market Cap
189.5m EUR
Industry
Health Care

Nightingale Health Oyj engages in the development of health data platform for healthcare service providers. The company is headquartered in Helsinki, Etela-Suomen and currently employs 77 full-time employees. The company went IPO on 2021-03-19. The blood analysis technology developed by Nightingale measures a broad group of biomarkers from a single blood sample, recognizing individual disease risks. The firm provides people with comprehensive insights on health, helps them make better decisions regarding their health and connects them with healthcare experts that offer preventative services for maintaining health. Nightingale Health Oy is the Parent Company in the Nightingale Group. The Group comprises the parent Company’s subsidiaries: Nightingale Health United States Inc, Nightingale Health Asia Pte Ltd, Nightingale Health Japan KK as well as NG Health Sweden AB. The firm owns and independently oversees two laboratories in Finland, in Helsinki and Kuopio, and one laboratory in Tokyo, Japan.

HEALTH Intrinsic Value
0.97 EUR
Overvaluation 69%
Intrinsic Value
Price
N

See Also

What is Nightingale Health Oyj's Cash from Financing Activities?
Cash from Financing Activities
-2.8m EUR

Based on the financial report for Jun 30, 2024, Nightingale Health Oyj's Cash from Financing Activities amounts to -2.8m EUR.

What is Nightingale Health Oyj's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-48%

Over the last year, the Cash from Financing Activities growth was -10%.

Back to Top